@article{lim2024,
  author = {Lim, M. and Xia, Y. and Bettegowda, C. and Weller, M.},
  title = {Immunotherapy for glioblastoma: current state, challenges, and future perspectives},
  journal = {Cellular and Molecular Immunology},
  year = {2024},
  volume = {21},
  number = {12},
  pages = {1354--1375},
  doi = {10.1038/s41423-024-01226-x}
}

@article{chen2024,
  author = {Chen, E. and Ling, A. L. and Reardon, D. A. and Chiocca, E. A.},
  title = {Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling?},
  journal = {Neuro-Oncology},
  year = {2024},
  volume = {26},
  number = {2},
  pages = {211--225},
  doi = {10.1093/neuonc/noad211}
}

@article{reardon2020,
  author = {Reardon, D. A. and Brandes, A. A. and Omuro, A. and others},
  title = {Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial},
  journal = {JAMA Oncology},
  year = {2020},
  volume = {6},
  number = {7},
  pages = {1003--1010},
  doi = {10.1001/jamaoncol.2020.1024}
}

@article{sayour2024,
  author = {Sayour, E. J. and others},
  title = {RNA aggregates harness the danger response for potent cancer immunotherapy},
  journal = {Cell},
  year = {2024},
  volume = {187},
  number = {10},
  pages = {2551--2568.e30},
  doi = {10.1016/j.cell.2024.03.098}
}

@article{oloruntimehin2025,
  author = {Oloruntimehin, S. and Akinyi, F. and Paul, M. and Ariyo, O.},
  title = {mRNA Vaccine Technology Beyond COVID-19},
  journal = {Vaccines},
  year = {2025},
  volume = {13},
  number = {6},
  pages = {601},
  doi = {10.3390/vaccines13060601}
}

@article{liau2023,
  author = {Liau, L. M. and Ashkan, K. and Brem, S. and others},
  title = {Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial},
  journal = {JAMA Oncology},
  year = {2023},
  volume = {9},
  number = {1},
  pages = {112--121},
  doi = {10.1001/jamaoncol.2022.5370}
}

@article{wang2025,
  author = {Barati, S. and others},
  title = {Promising Cancer Vaccine for Glioblastoma Therapy: A Focus on mRNA Vaccines},
  journal = {Cancer Medicine},
  year = {2025},
  volume = {14},
  number = {9},
  pages = {e71187},
  doi = {10.1002/cam4.71187}
}

@article{karimi2024,
  author = {Karimi-Sani, I. and Molavi, Z. and Naderi, S.-H. and Zare, I. and Naeimzadeh, Y. and Mansouri, A. and Tajbakhsh, A. and Savardashtaki, A. and Sahebkar, A.},
  title = {Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials},
  journal = {Journal of Nanobiotechnology},
  year = {2024},
  volume = {22},
  number = {1},
  pages = {601},
  doi = {10.1186/s12951-024-02882-x}
}

@article{shen2024,
  author = {Shen, Y. and Qian, J. and others},
  title = {Vaccine-based immunotherapy in glioblastoma: evolving strategies},
  journal = {Frontiers in Oncology},
  year = {2024},
  volume = {14},
  pages = {1445832},
  doi = {10.3389/fonc.2024.1445832}
}

@article{manfredi2024,
  author = {Manfredi, F. and Rossi, D. and others},
  title = {Lipid nanoparticle platforms for RNA delivery in CNS oncology},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {7},
  pages = {885},
  doi = {10.3390/pharmaceutics16070885}
}

@article{meng2020,
  author = {Meng, Q. and others},
  title = {Blood-Brain Barrier Disruption in Neuro-Oncology},
  journal = {Frontiers in Oncology},
  year = {2020},
  volume = {10},
  pages = {563840},
  doi = {10.3389/fonc.2020.563840}
}

@article{chen2024fus,
  author = {Chen, K.-T. and Chai, W.-X. and Wei, K.-C.},
  title = {Focused ultrasound-mediated enhancement of bloodâ€“brain barrier permeability for brain tumor treatment: a systematic review of clinical trials},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  volume = {169},
  number = {3},
  pages = {1--14},
  doi = {10.1007/s11060-024-04795-z}
}

@article{aunins2025,
  author = {Aunins, E. A. and others},
  title = {An IL-12 mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responses},
  journal = {Science Immunology},
  year = {2025},
  volume = {10},
  number = {108},
  pages = {eads1328},
  doi = {10.1126/sciimmunol.ads1328}
}

@article{tapescu2024,
  author = {Tapescu, I. and Dricu, A. and others},
  title = {The transformative potential of mRNA vaccines for glioblastoma and other solid tumours: technological advances and translation to clinical trials},
  journal = {Frontiers in Oncology},
  year = {2024},
  volume = {14},
  pages = {1454370},
  doi = {10.3389/fonc.2024.1454370}
}

@article{lai2018,
  author = {Lai, I. and Swaminathan, S. and Baylot, V. and others},
  title = {Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma},
  journal = {Journal of Immunotherapy of Cancer},
  year = {2018},
  volume = {6},
  number = {1},
  pages = {125},
  doi = {10.1186/s40425-018-0431-x}
}

@article{ammi2015,
  author = {Ammi, R. and De Waele, J. and Willemen, Y. and others},
  title = {Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs},
  journal = {Pharmacology and Therapeutics},
  year = {2015},
  volume = {146},
  pages = {120--131},
  doi = {10.1016/j.pharmthera.2014.09.010}
}

@article{jiang2023,
  author = {Jiang, Y. and Zhang, H. and Wang, J. and others},
  title = {Exploiting RIG-I-like receptor pathway for cancer immunotherapy},
  journal = {Journal of Hematology and Oncology},
  year = {2023},
  volume = {16},
  number = {1},
  pages = {8},
  doi = {10.1186/s13045-023-01405-9}
}

@article{han2025,
  author = {Han, E. L. and Badrinarayanan, S. and others},
  title = {Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain},
  journal = {Nano Letters},
  year = {2025},
  volume = {25},
  number = {2},
  pages = {800--810},
  doi = {10.1021/acs.nanolett.4c05186}
}

@article{hilf2024,
  author = {Hilf, N. and others},
  title = {A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine},
  journal = {Nature Communications},
  year = {2024},
  volume = {15},
  number = {1},
  pages = {6870},
  doi = {10.1038/s41467-024-51315-8}
}